References

  1. Pol S, Vallet-Pichard A, Corouge M, Mallet VO. Hepatitis C: epidemiology, diagnosis, natural history and therapy. Contrib Nephrol. 2012; 176:1-9. PubMed | Google Scholar

  2. Alashek WA, McIntyre CW, Taal MW. Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors. BMC Infect Dis. 2012 Oct 20; 12:265. PubMed | Google Scholar

  3. Morikawa T, Nakata K, Hamasaki K, Tsuruta S, Kato Y, Nakao K, Ohtsubo T, Eguchi K. Prevalence and characterization of hepatitis C virus in hemodialysis patients. Intern Med. 1999 Aug; 38(8):626-31. PubMed | Google Scholar

  4. Niu MT, Coleman PJ, Alter MJ. Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and hemodialysis center staff members. Am J Kidney Dis. 1993 Oct; 22(4):568-73. PubMed | Google Scholar

  5. Salama G, Rostaing L, Sandres K, Izopet J. Hepatitis C virus infection in French hemodialysis units: a multicenter study. J Med Virol. 2000 May; 61(1):44-51. PubMed | Google Scholar

  6. Jaiswal SP1, Chitnis DS, Naik G, Artwani KK, Pandit CS, Salgia P, Sepaha A. Prevalence of anti-HCV antibodies in central India. Indian J Med Res. 1996 Aug; 104:177-81. PubMed | Google Scholar

  7. Hardy NM, Sandroni S, Danielson S, Wilson WJ. Antibody to hepatitis C virus increases with time on hemodialysis. Clin Nephrol. 1992 Jul; 38(1):44-8. PubMed | Google Scholar

  8. Okuda K1, Hayashi H, Kobayashi S, Irie Y. Mode of hepatitis C infection not associated with blood transfusion among chronic hemodialysis patients. J Hepatol. 1995 Jul; 23(1):28-31. PubMed | Google Scholar

  9. Kalantar-Zadeh K, McAllister CJ, Miller LG. Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population based study. Nephrol Dial Transplant. 2005 Aug; 20(8):1662-9. PubMed | Google Scholar

  10. Cockcroft D,Gault M. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16: 31-41. PubMed | Google Scholar

  11. Denue BA, Ajayi BB, Abja AU, Bukar AA, Akawu C, Ekong E, Alkali MB. Survey of Prevalence of Hepatitis B and C in a tertiary health institution in northeastern Nigeria. International Journal of Medicine and Medical Sciences. 2012; 4(1): 13-18. PubMed | Google Scholar

  12. Medin C, Allander T, Roll M, Jacobson SH, Grillner L. Seroconversion to hepatitis C virus in dialysis patients: a retrospective and prospective study. Nephron. 1993; 65(1):40-5. PubMed | Google Scholar

  13. Hayashi J, Nakashima K, Kajiyama W, Noguchi A, Morofuji M, Maeda Y, Kashiwagi S. Prevalence of antibody to hepatitis C virus in hemodialysis patients. Am J Epidemiol. 1991 Sep 15; 134(6):651-7. PubMed | Google Scholar

  14. Schlipköter U, Gladziwa U, Cholmakov K, Weise A, Rasshofer R, Lorbeer B, Luz N, Deinhardt F, Roggendorf M. Prevalence of hepatitis C virus infections in dialysis patients and their contacts using a second generation enzymed-linked immunosorbent assay. Med Microbiol Immunol. 1992; 181(3):173-80. PubMed | Google Scholar

  15. Thorburn D, Dundas D, McCruden EA, Cameron SO, Goldberg DJ, Symington IS, Kirk A, Mills PR. A study of hepatitis C prevalence in healthcare workers in the West of Scotland. Gut. 2001 Jan; 48(1):116-20. PubMed | Google Scholar

  16. Thomas DL, Factor SH, Kelen GD, Washington AS, Taylor E Jr, Quinn TC. Viral hepatitis in health care personnel at The Johns Hopkins Hospital: The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Arch Intern Med. 1993 Jul 26; 153(14):1705-12. PubMed | Google Scholar

  17. Neal KR, Dornan J, Irving WL. Prevalence of hepatitis C antibodies among healthcare workers of two teaching hospitals Who is at risk? BMJ. 1997 Jan 18; 314(7075):179-80. PubMed | Google Scholar

&